An Evidence-Based Guideline Improves Outcomes for Patients With Hemophagocytic Lymphohistiocytosis and Macrophage Activation Syndrome.
J Rheumatol
; 49(9): 1042-1051, 2022 Sep.
Article
in En
| MEDLINE
| ID: mdl-35840156
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Lymphohistiocytosis, Hemophagocytic
/
Macrophage Activation Syndrome
Type of study:
Diagnostic_studies
/
Guideline
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Child
/
Humans
Language:
En
Journal:
J Rheumatol
Year:
2022
Document type:
Article
Country of publication:
Canadá